Phio amends 2020 Long Term Incentive Plan
Phio Pharmaceuticals has amended its 2020 Long-Term Incentive Plan to increase the reserved shares of common stock by 1,500,000 pending stockholder approval. This amendment is intended to support future stock-based compensation programs.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
START FREE — 10,000 calls/day, no key needed